Sophiris Bio Inc. (SHS.TO) To Present At The 13th Annual Needham Healthcare Conference
3/26/2014 6:37:43 AM
Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company developing a clinical stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH) or enlarged prostate, today announced that Randall E. Woods, president and chief executive officer, will present a corporate overview at the 13th Annual Needham Healthcare Conference. The presentation is scheduled for Tuesday, April 8th at 3:00 p.m. EDT at the Westin Grand Central Hotel in New York, New York.
Help employers find you! Check out all the jobs and post your resume.
comments powered by